Oncology

News

Ultomiris fail mars AZ's strong Q2 results

AstraZeneca has served up a robust set of interim results, leavened by strong sales of cancer drugs, but with some mixed pipeline news on the side.

News

J&J's multiple myeloma duo aces phase 3 trial

Two of Johnson & Johnson's multiple myeloma bispecifics, Tecvayli and Talvey, have dramatically improved survival when used as a second-line regimen.

News

EU clears AZ's SERD camizestrant, as FDA review drags on

AstraZeneca's new breast cancer therapy Etcamah claims landmark frontline approval in the EU, but its prospects in the US are less certain.

News

Nuvalent buy delivers new cancer approval for GSK

GSK has its first approval from the $10.6bn takeover of Nuvalent, ROS1+ NSCLC therapy Jideytro, which becomes the company's first lung cancer product.

News

Celcuity gets FDA nod for first-in-class breast cancer drug

Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of breast cancer.

News

Digital check-ins improve cancer care and reduce inequality

A study has shown that, for people living with advanced cancer, a weekly remote check-in with the care team can have a significant impact on outcomes.

Ultomiris fail mars AZ's strong Q2 results

J&J's multiple myeloma duo aces phase 3 trial

EU clears AZ's SERD camizestrant, as FDA review drags on

Nuvalent buy delivers new cancer approval for GSK

Celcuity gets FDA nod for first-in-class breast cancer drug

Digital check-ins improve cancer care and reduce inequality

Beacon's XLRP gene therapy set for filing after phase 3 win

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks